ES2069146T3 - Medicamentos que contienen derivados sustituidos de 2-ciclohexeno-1-il-amina y su uso para combatir enfermedades. - Google Patents

Medicamentos que contienen derivados sustituidos de 2-ciclohexeno-1-il-amina y su uso para combatir enfermedades.

Info

Publication number
ES2069146T3
ES2069146T3 ES91114115T ES91114115T ES2069146T3 ES 2069146 T3 ES2069146 T3 ES 2069146T3 ES 91114115 T ES91114115 T ES 91114115T ES 91114115 T ES91114115 T ES 91114115T ES 2069146 T3 ES2069146 T3 ES 2069146T3
Authority
ES
Spain
Prior art keywords
cycllohexeno
amine
substituted derivatives
containing substituted
medicines containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91114115T
Other languages
English (en)
Inventor
Franz Dr Kunisch
Peter Dr Babczinski
Dieter Prof Dr Arlt
Manfred Dr Plempel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2069146T3 publication Critical patent/ES2069146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UN DERIVADO DE 2-CICLOHEXENO SUSTITUIDO DE FORMULA (I) Y DESCRIBE SU APLICACION EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS BACTERIALES Y MICOSIS, TENIENDO R SUB 1, R SUB 2, R SUB 3, R SUB 4 Y A UN SIGNIFICADO DESCRITO EN LA PATENTE.
ES91114115T 1990-09-05 1991-08-23 Medicamentos que contienen derivados sustituidos de 2-ciclohexeno-1-il-amina y su uso para combatir enfermedades. Expired - Lifetime ES2069146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4028046A DE4028046A1 (de) 1990-09-05 1990-09-05 Arzneimittel enthaltend substituierte 2-cyclohexen-1-yl-amin-derivate und ihre verwendung zur bekaempfung von krankheiten

Publications (1)

Publication Number Publication Date
ES2069146T3 true ES2069146T3 (es) 1995-05-01

Family

ID=6413581

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91114115T Expired - Lifetime ES2069146T3 (es) 1990-09-05 1991-08-23 Medicamentos que contienen derivados sustituidos de 2-ciclohexeno-1-il-amina y su uso para combatir enfermedades.

Country Status (16)

Country Link
US (1) US5296503A (es)
EP (1) EP0478941B1 (es)
JP (1) JPH04279553A (es)
AT (1) ATE117896T1 (es)
AU (1) AU8360191A (es)
CA (1) CA2050402A1 (es)
DE (2) DE4028046A1 (es)
DK (1) DK0478941T3 (es)
ES (1) ES2069146T3 (es)
FI (1) FI914138A7 (es)
GR (1) GR3015592T3 (es)
HU (1) HU912862D0 (es)
IE (1) IE913112A1 (es)
IL (1) IL99369A0 (es)
PT (1) PT98850A (es)
ZA (1) ZA917001B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1309659A (zh) 1998-07-15 2001-08-22 哈桑·朱马 有机磷化合物及其用途
US11512041B2 (en) 2019-12-04 2022-11-29 Nanyang Technological University Highly enantioselective access to cyclic beta-amino acids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1233354A (es) * 1968-08-02 1971-05-26
CA972362A (en) * 1970-10-12 1975-08-05 Hirotomo Masuya Penicillins and cephalosporins
US3882164A (en) * 1972-06-26 1975-05-06 Warner Lambert Co Dextrorotatory 3r-n-monomethyl-amino-4c-phenyl-4t-ethoxycarbonicyclohexene-1 and process for the production thereof
DE2243803A1 (de) * 1972-09-07 1974-03-21 Upjohn Co In 4-stellung durch einen aromatischen rest substituierte eckige klammer auf (3-cyclohexen-1-yl)-amino eckige klammer zu -butyropenone, deren saeureanlagerungssalze und verfahren zur herstellung dieser verbindungen
DE3126818A1 (de) * 1981-07-08 1983-01-27 Basf Ag, 6700 Ludwigshafen N-(3-(4'-tert.-butyl-cyclohexen-3'-yl)-2-methyl-propyl-1)-cycloalkylamine, verfahren zu ihrer herstellung und diese enthaltende antimykotische mittel
DE3408540A1 (de) * 1984-03-08 1985-09-19 Bayer Ag, 5090 Leverkusen Fungizide mittel
DE3630344A1 (de) * 1986-09-05 1988-03-17 Basf Ag 4-substituierte cyclohexylamine und cyclohexenylamine, diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen
DE58906997D1 (de) * 1988-12-27 1994-03-24 Bayer Ag Fungizide und herbizide Mittel sowie substituierte 2-Cyclohexen-1-yl-amin-Derivate und deren Herstellung.
ATE140213T1 (de) * 1990-03-08 1996-07-15 Fujisawa Pharmaceutical Co N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament

Also Published As

Publication number Publication date
DK0478941T3 (da) 1995-06-12
PT98850A (pt) 1992-07-31
EP0478941B1 (de) 1995-02-01
AU8360191A (en) 1992-03-12
ATE117896T1 (de) 1995-02-15
DE59104473D1 (de) 1995-03-16
IE913112A1 (en) 1992-03-11
HUT61893A (en) 1993-03-29
GR3015592T3 (en) 1995-06-30
HU912862D0 (en) 1993-03-29
JPH04279553A (ja) 1992-10-05
FI914138A7 (fi) 1992-03-06
CA2050402A1 (en) 1992-03-06
EP0478941A1 (de) 1992-04-08
DE4028046A1 (de) 1992-03-12
IL99369A0 (en) 1992-08-18
US5296503A (en) 1994-03-22
FI914138A0 (fi) 1991-09-03
ZA917001B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2195970T3 (es) L-ribavirina y usos de la misma.
FI931250A0 (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
IT1285770B1 (it) Composti corticoidei
ES2156120T3 (es) Derivados arilamidicos.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
FI944770A0 (fi) Neurotensiiniin vaikuttavia substituoituja 1-naftyylipyratsoli-3-karboksiamideja, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 478941

Country of ref document: ES